HIV specific responses induced in nonhuman primates with ANRS HIV-Lipo-5 vaccine combined with rMVA-HIV prime or boost immunizations. Issue 20 (11th May 2015)

• Record Type: Journal Article
• Authors: Dereuddre-Bosquet, Nathalie; Baron, Marie-Laurence; Contreras, Vanessa; Gosse, Leslie; Mangeot, Isabelle; Martinon, Frédéric; Yousfi, Rahima; Clayette, Pascal; Levy, Yves; Le Grand, Roger; Vaccine Research Institute
• Is Part Of: Vaccine. Volume 33:Issue 20(2015)
• Page Start: 2354
• Page End: 2359
• Publication Date: 2015-05-11
• Subjects: Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2015.03.032
• Languages: English
• ISSNs: 0264-410X

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">A priming/booster strategy combining HIV LAI lipopeptides and rMVA enhances specific T-cell responses.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">rMVA immunizations, unlike HIV-Lipo-5 immunizations, do not elicit detectable anti-HIV Ab response.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Lipopeptide priming and live attenuated virus vector booster combination may be appropriate for therapeutic immunization in HIV infected patients.</p> </list-item> </list> </p> </sec> </abstract>